Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 19 studies | 40% ± 21% | |
monocyte | 11 studies | 34% ± 20% | |
conventional dendritic cell | 10 studies | 23% ± 7% | |
non-classical monocyte | 9 studies | 32% ± 17% | |
macrophage | 8 studies | 34% ± 14% | |
dendritic cell | 6 studies | 26% ± 7% | |
hematopoietic stem cell | 6 studies | 32% ± 11% | |
myeloid cell | 4 studies | 28% ± 13% | |
hematopoietic precursor cell | 3 studies | 26% ± 11% | |
squamous epithelial cell | 3 studies | 26% ± 10% | |
mononuclear phagocyte | 3 studies | 28% ± 12% | |
basal cell | 3 studies | 25% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 4 studies | 24% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 90% | 967.64 | 1304 / 1445 | 63% | 21.40 | 115 / 183 |
intestine | 63% | 186.51 | 606 / 966 | 71% | 27.27 | 374 / 527 |
lung | 88% | 586.08 | 509 / 578 | 32% | 12.41 | 375 / 1155 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.43 | 1 / 1 |
skin | 83% | 1359.32 | 1504 / 1809 | 8% | 1.87 | 38 / 472 |
stomach | 13% | 35.99 | 48 / 359 | 53% | 24.82 | 151 / 286 |
bladder | 10% | 32.00 | 2 / 21 | 48% | 20.31 | 244 / 504 |
pancreas | 4% | 8.57 | 12 / 328 | 51% | 8.72 | 90 / 178 |
peripheral blood | 47% | 308.26 | 436 / 929 | 0% | 0 | 0 / 0 |
spleen | 36% | 109.98 | 87 / 241 | 0% | 0 | 0 / 0 |
adipose | 36% | 202.38 | 429 / 1204 | 0% | 0 | 0 / 0 |
breast | 19% | 49.98 | 85 / 459 | 11% | 1.52 | 122 / 1118 |
uterus | 5% | 28.15 | 9 / 170 | 23% | 4.67 | 105 / 459 |
blood vessel | 23% | 73.40 | 313 / 1335 | 0% | 0 | 0 / 0 |
heart | 22% | 73.55 | 187 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 20% | 3.47 | 9 / 45 |
kidney | 6% | 20.28 | 5 / 89 | 11% | 1.18 | 95 / 901 |
thymus | 1% | 2.30 | 9 / 653 | 13% | 1.03 | 76 / 605 |
liver | 5% | 13.60 | 12 / 226 | 7% | 1.41 | 30 / 406 |
ovary | 7% | 10.74 | 12 / 180 | 3% | 0.18 | 13 / 430 |
prostate | 7% | 15.78 | 17 / 245 | 0% | 0.02 | 2 / 502 |
adrenal gland | 2% | 2.50 | 4 / 258 | 2% | 1.03 | 5 / 230 |
brain | 0% | 1.20 | 10 / 2642 | 2% | 0.24 | 17 / 705 |
muscle | 1% | 1.07 | 6 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042327 | Biological process | positive regulation of phosphorylation |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0030216 | Biological process | keratinocyte differentiation |
GO_0001525 | Biological process | angiogenesis |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0051781 | Biological process | positive regulation of cell division |
GO_0048146 | Biological process | positive regulation of fibroblast proliferation |
GO_0043434 | Biological process | response to peptide hormone |
GO_0009887 | Biological process | animal organ morphogenesis |
GO_0048661 | Biological process | positive regulation of smooth muscle cell proliferation |
GO_0007143 | Biological process | female meiotic nuclear division |
GO_0051151 | Biological process | negative regulation of smooth muscle cell differentiation |
GO_0050680 | Biological process | negative regulation of epithelial cell proliferation |
GO_0007267 | Biological process | cell-cell signaling |
GO_0045089 | Biological process | positive regulation of innate immune response |
GO_0042700 | Biological process | luteinizing hormone signaling pathway |
GO_0042060 | Biological process | wound healing |
GO_0001556 | Biological process | oocyte maturation |
GO_0045860 | Biological process | positive regulation of protein kinase activity |
GO_0048160 | Biological process | primary follicle stage |
GO_0038138 | Biological process | ERBB4-ERBB4 signaling pathway |
GO_0030728 | Biological process | ovulation |
GO_0038134 | Biological process | ERBB2-EGFR signaling pathway |
GO_0045740 | Biological process | positive regulation of DNA replication |
GO_0001550 | Biological process | ovarian cumulus expansion |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0007173 | Biological process | epidermal growth factor receptor signaling pathway |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0038135 | Biological process | ERBB2-ERBB4 signaling pathway |
GO_0001819 | Biological process | positive regulation of cytokine production |
GO_0009299 | Biological process | mRNA transcription |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045840 | Biological process | positive regulation of mitotic nuclear division |
GO_0043616 | Biological process | keratinocyte proliferation |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0030669 | Cellular component | clathrin-coated endocytic vesicle membrane |
GO_0048018 | Molecular function | receptor ligand activity |
GO_0005154 | Molecular function | epidermal growth factor receptor binding |
GO_0008083 | Molecular function | growth factor activity |
GO_0030297 | Molecular function | transmembrane receptor protein tyrosine kinase activator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | EREG |
Protein name | Proepiregulin [Cleaved into: Epiregulin (EPR)] Alternative protein EREG |
Synonyms | |
Description | FUNCTION: Ligand of the EGF receptor/EGFR and ERBB4. Stimulates EGFR and ERBB4 tyrosine phosphorylation . Contributes to inflammation, wound healing, tissue repair, and oocyte maturation by regulating angiogenesis and vascular remodeling and by stimulating cell proliferation . . |
Accessions | ENST00000244869.3 O14944 L8E9W3 |